GNLX:NASDAQGenelux Corporation Analysis
Data as of 2026-09-30 - not real-time
$2.53
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Genelux Corporation is priced at $2.53 and its moving averages line up in bearish order, the shorter trailing the longer. The last 30 days have lost 2.7%. With RSI at 48.6 the momentum picture is neutral, alongside a bullish MACD signal. Price has been bracketed by support at $2.31 and resistance at $2.73.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 644.4% above where the shares trade now.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 50.4%, a beta of 2.22 and a maximum drawdown of 72.1%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Short, medium and long-term reads agree on sell, with conviction of 4/10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 644.4% above where the shares trade now.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 50.4%, a beta of 2.22 and a maximum drawdown of 72.1%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Short, medium and long-term reads agree on sell, with conviction of 4/10.
Top Market Events
Taiwan News1monGenelux Corporation Reports Second Quarter Financial Results and Provides Business Updates-- Recently...finanzen.at22dISpecimen In Focus, Genelux Nears Phase 3 Ovarian Cancer Data, Biofrontera Awaits FDA Decision RTTNews -...
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 2.86
- MACD momentum is positive
Medium Term
1–3 yearsCautious
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 2.86
- Analyst targets imply +644.4% versus the current price
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Analyst targets imply +644.4% versus the current price
- Negative return on equity of -177.9%
- Negative free cash flow
Key Metrics & Analysis
Financial Health
P/E Ratio-3.4
ROE-177.93%
ROA-77.89%
Debt/Equity15.02
P/B Ratio7.0
Op. Cash Flow$-25277000
Free Cash Flow$-15252750
Industry P/E30.1
Technical Analysis
TrendBearish
RSI48.6
Support$2.31
Resistance$2.73
MA 20$2.50
MA 50$2.66
MA 200$2.86
MACDBullish
VolumeDecreasing
Fear & Greed Index92.25
Valuation
Target Price$18.83
Upside/Downside644.40%
GradeFair
TypeGrowth
Risk Assessment
Beta2.22
Volatility50.42%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.